Mechanical Ventilation Clinical Trial
— Wean-TrachOfficial title:
Invasive Mechanical Ventilation With Tracheostomy - an Observational Study on Patient-centered Outcomes
NCT number | NCT05906888 |
Other study ID # | W23.001 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 8, 2023 |
Est. completion date | December 31, 2024 |
Background: It is largely undocumented how long it takes to wean from invasive mechanical ventilation (IMV) with tracheostomy and to what extend these patients suffer from dyspnea or discomfort and how often sputum retention occurs requiring burdensome endotracheal suctioning. In patients undergoing invasive mechanical ventilation via endotracheal tube, dyspnea is prevalent and associated with poorer quality of life and more symptoms of post-traumatic stress disorder (PTSD) Objectives: The present study aims to assess the duration of the weaning period, and the prevalence and severity of dyspnea and discomfort in patients with tracheostomy-facilitated weaning. Study design: Prospective observational multicenter cohort study. Study population: Tracheostomized critically ill patients weaning from IMV. Main study parameters/endpoints: Prevalence and severity of dyspnea and discomfort during weaning, duration of weaning with tracheostomy, frequency of endotracheal suctioning, time with tracheostomy, clinical outcomes, and mortality rates. Long term outcomes are the prevalence quality of life, PTSD, anxiety and fear.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | December 31, 2024 |
Est. primary completion date | May 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Aged =18 years - Scheduled to start weaning from iMV, as per clinical decision Exclusion Criteria: - Deafness or Blindness - Inability to speak or comprehend Dutch and English language - Neuromuscular Disease - Chronic positive pressure respiratory support at home (excluding night-time CPAP for sleep apnea) - Support by Ventricular Assist Device or Extracorporeal life support (ECMO or ECCO2R) during tracheostomy-facilitated weaning phase. - Tracheostomy primarily indicated for chronic upper airway obstruction or to secure airway patency due to persistent stupor/coma or swallowing disorder |
Country | Name | City | State |
---|---|---|---|
Netherlands | Rijnstate Ziekenhuis | Arnhem | |
Netherlands | Amphia Ziekenhuis | Breda | |
Netherlands | IJsselland Ziekenhuis | Capelle Aan Den IJssel | |
Netherlands | Reinier de Graaf Gasthuis | Delft | |
Netherlands | Jeroen Bosch Ziekenhuis | Den Bosch | |
Netherlands | Haags Medisch Centrum Westeinde | Den Haag | |
Netherlands | Catharina Ziekenhuis | Eindhoven | |
Netherlands | Maxima Medisch Centrum | Eindhoven | |
Netherlands | St Anna ziekenhuis | Geldrop | |
Netherlands | Spaarne Gasthuis | Haarlem | |
Netherlands | Erasmus MC | Rotterdam | |
Netherlands | Franciscus Gasthuis & Vlietland | Rotterdam | |
Netherlands | Ikazia Ziekenhuis | Rotterdam | |
Netherlands | Elizabeth-Tweesteden Ziekenhuis | Tilburg |
Lead Sponsor | Collaborator |
---|---|
Henrik Endeman | Franciscus &Vlietland |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Daily dyspnea score during disconnection session | The severity of dyspnea during disconnection from mechanical ventilation | During repeated disconnection sessions in the first 28 days after initiation of weaning with tracheostomy, once daily an assessment is made using Visual Analog Scale for Dyspnea. (0-10). Higher scores indicate higher levels of dyspnea. | |
Secondary | Duration of tracheostomy in situ | Within the first 56 days after tracheostomy placement | ||
Secondary | Mortality | 28-day, 56-day, ICU- and in-hospital mortality | Within the first 56 days after tracheostomy placement | |
Secondary | Health-related Quality of Life (HR-QoL) | The HR-QoL, as measured with the EQ5D-5L questionnaire. High scores indicate a high level of perceived problems. | 3 months after ICU discharge | |
Secondary | Health-related Quality of Life (HR-QoL) | The HR-QoL, as measured with the EQ-VAS (0-100). High scores indicate a high level of self-reported HR-QoL. | 3 months after ICU discharge | |
Secondary | Post-traumatic stress Disorder (PTSD) | The presence PTSD-related symptoms, as measured with the IES-6 questionnaire | 3 months after ICU discharge | |
Secondary | Anxiety and Depression | The presence of long-term symptoms of anxiety and/or depression as measured with the Hospital-related Anxiety and Depression Scale (HADS) questionnaire. | 3 months after ICU discharge | |
Secondary | Endotracheal suctioning | Number of endotracheal suctioning manoeuvres during the weaning phase | In the first 28 days after weaning initiation | |
Secondary | Weaning duration | The time between the first disconnection session with tracheostomy and separation attempt after tracheostomy placement until disconnection from the ventilator for =7 consecutive days, or ICU discharge, whichever comes first. | Within the first 28 days after the first disconnection session. | |
Secondary | Daily discomfort score during disconnection session | The severity of discomfort | During repeated disconnection sessions in the first 28 days after initiation of weaning with tracheostomy, once daily an assessment is made using Visual Analog Scale for Discomfort (0-10). Higher scores indicate higher levels of discomfort. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05921656 -
Construction and Evaluation of Airway Leakage Risk Model of Patients With Endotracheal Tube
|
||
Recruiting |
NCT03941002 -
Continuous Evaluation of Diaphragm Function
|
N/A | |
Withdrawn |
NCT04288076 -
The Brain and Lung Interaction (BALI) Study
|
N/A | |
Completed |
NCT03031860 -
Semi-quantitative Cough Strength Score (SCSS)
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Completed |
NCT02312869 -
Local Assessment of Management of Burn Patients
|
N/A | |
Completed |
NCT01885442 -
TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients
|
N/A | |
Completed |
NCT01204281 -
Proportional Assist Ventilation (PAV) in Early Stage of Critically Ill Patients
|
Phase 4 | |
Terminated |
NCT01059929 -
Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)
|
Phase 4 | |
Completed |
NCT00824239 -
Intermittent Sedation Versus Daily Interruption of Sedation in Mechanically Ventilated Patients
|
Phase 3 | |
Completed |
NCT00529347 -
Mechanical Ventilation Controlled by the Electrical Activity of the Patient's Diaphragm - Effects of Changes in Ventilator Parameters on Breathing Pattern
|
Phase 1 | |
Unknown status |
NCT00260676 -
Protective Ventilatory Strategy in Potential Organ Donors
|
Phase 3 | |
Terminated |
NCT00205517 -
Sedation and Psychopharmacology in Critical Care
|
N/A | |
Completed |
NCT03281785 -
Ultrasound of Diaphragmatic Musculature in Mechanically Ventilated Patients.
|
N/A | |
Recruiting |
NCT04110613 -
RCT: Early Feeding After PEG Placement
|
N/A | |
Completed |
NCT04410783 -
The Emergency Department Sedation Pilot Trial
|
N/A | |
Recruiting |
NCT04821453 -
NAVA vs. CMV Crossover in Severe BPD
|
N/A | |
Completed |
NCT03930147 -
Ventilation With ASV Mode in Children
|
N/A | |
Recruiting |
NCT05029167 -
REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study)
|
N/A | |
Recruiting |
NCT04849039 -
Lung Microbiota and VAP Development (PULMIVAP)
|